Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Day One Biopharmaceuticals, Inc. (DAWN)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 87,040,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co. is engaged in developing and commercializing targeted therapies for patients with genomically-defined cancers. Co.'s main product candidate, DAY101 (tovorafenib), is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Co.'s second product candidate, pimasertib, is an oral, highly-selective small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK), a well-characterized key signaling node in the RAS/mitogen-activated protein kinase pathway.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,244,684 4,978,018
Total Buy Value $0 $0 $24,978,318 $65,978,328
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 4 7
Total Shares Sold 219,672 235,453 251,353 4,535,329
Total Sell Value $3,760,339 $4,000,968 $4,202,088 $62,286,378
Total People Sold 3 4 4 8
Total Sell Transactions 11 15 23 104
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 183
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-05-16 4 S $16.08 $43,011 D/D (2,675) 224,868     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-05-16 4 S $16.08 $36,450 D/D (2,267) 1,171,081     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2024-05-16 4 S $16.08 $52,304 D/D (3,253) 21,731     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-16 4 S $16.08 $126,588 D/D (7,873) 654,728     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-05-15 4 OE $0.00 $0 D/D 10,250 227,543     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-05-15 4 OE $0.00 $0 D/D 8,686 1,173,348     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2024-05-15 4 OE $0.00 $0 D/D 8,399 24,984     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-15 4 OE $0.00 $0 D/D 19,999 662,601     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-05-10 4 AS $16.37 $163,743 D/D (10,000) 1,164,662     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-03 4 AS $17.85 $163,417 D/D (9,154) 642,602     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-05-03 4 AS $17.85 $144,214 D/D (8,078) 217,293     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-02 4 AS $17.94 $108 D/D (6) 651,756     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-05-02 4 AS $17.90 $3,579 D/D (200) 225,371     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-01 4 AS $17.88 $1,252,183 D/D (70,051) 651,762     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-05-01 4 AS $17.89 $933,397 D/D (52,183) 225,571     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-04-18 4 AS $16.02 $160,163 D/D (10,000) 1,174,662     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-03-25 4 AS $16.01 $160,055 D/D (10,000) 1,184,662     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-03-11 4 AS $15.24 $457,314 D/D (30,000) 1,194,662     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-02-27 4 AS $16.11 $322,166 D/D (20,000) 1,224,662     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-02-16 4 S $15.25 $40,651 D/D (2,666) 277,754     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2024-02-16 4 S $15.25 $49,434 D/D (3,242) 16,585     -
   Blackman Samuel C. HEAD OF RESEARCH AND DEVELOPME   •       –      –    2024-02-16 4 S $15.25 $34,430 D/D (2,258) 1,244,662     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2024-02-16 4 S $15.25 $116,114 D/D (7,615) 721,813     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 10,250 280,420     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 8,399 19,827     -
  183 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us